Translate Bio Inc (TBIO)

NASDAQ
37.36
0.00(0.00%)
  • Volume:
    0
  • Day's Range:
    37.16 - 37.64
  • 52 wk Range:
    15.84 - 37.98

TBIO Overview

Prev. Close
37.36
Day's Range
37.16-37.64
Revenue
225.09M
Open
37.42
52 wk Range
15.84-37.98
EPS
0.5
Volume
0
Market Cap
2.82B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
3,859,617
P/E Ratio
74.64
Beta
-
1-Year Change
0%
Shares Outstanding
75,590,892
Next Earnings Date
-
What is your sentiment on Translate Bio?
or
Vote to see community's results!

Translate Bio Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Translate Bio Inc Analysis

Translate Bio Inc Company Profile

Translate Bio Inc Company Profile

Employees
122
  • Type:Equity
  • Market:United States
  • ISIN:US89374L1044
  • CUSIP:00089374L104

Translate Bio, Inc., a clinical-stage messenger RNA (mRNA) therapeutics company, develops medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, which is in Phase I/II clinical trial for the treatment of cystic fibrosis. It is also developing MRT5500 for the treatment of SARS-CoV-2. The company was formerly known as RaNA Therapeutics, Inc. and changed its name to Translate Bio, Inc. in June 2017. Translate Bio, Inc. has a collaboration and license agreement with Sanofi Pasteur Inc. The company was founded in 2011 and is headquartered in Lexington, Massachusetts. As of September 13, 2021, Translate Bio, Inc. operates as a subsidiary of Sanofi.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellBuyStrong Buy
Technical IndicatorsStrong SellStrong SellStrong SellBuyStrong Buy
SummaryStrong SellStrong SellStrong SellBuyStrong Buy
  • The upcoming merger is not what shareholders wanted!
    0
    • 17.5
      3
      • Sanofi to restart trial of covid vaccine after facing delays🚀🚀🚀
        1
        • 🚀🚀🚀lets go
          1
          • it's going back up again or I should take the loss and sell it?
            1
            • what happened with this company? Anyone knows it?
              0
              • Sanofi is backing them
                0
              • 👍 Then Im in
                0